---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-027467"
form_type: "8-K"
ticker: "INBP"
cik: "0001016504"
company_name: "INTEGRATED BIOPHARMA INC"
filed_at: "2021-11-29T23:59:59+00:00"
generated_at: "2026-06-28T05:02:46.414295+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# 2021 annual meeting results: directors elected, executive compensation approved, auditor ratified

## Summary
- E Gerald Kay, Riva Sheppard, and Carl DeSantis elected as Class I directors until 2024 annual meeting.
- Non-binding advisory vote on executive compensation approved with 20.2M for, 0.7M against, 2.1M abstain.
- Ratification of Friedman LLP as independent auditor for FY ending June 30, 2022 approved (23.8M for, 6.4K against).
- Total shares voted: 24.1M out of 29.8M eligible (quorum present).

## SEC filing metadata
- accession: 0001437749-21-027467
- form_type: 8-K
- ticker: INBP
- cik: 0001016504
- company_name: INTEGRATED BIOPHARMA INC
- filed_at: 2021-11-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1016504/000143774921027467/0001437749-21-027467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1016504/000143774921027467/inbp20211129_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-027467
- JSON: https://secwatch.observer/filing/0001437749-21-027467.json
- Plain text: https://secwatch.observer/filing/0001437749-21-027467.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.